Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML. Xie J, Bao X, Xue SL, Shen H, et al. Blood 2023;142:1323-1327.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xie J, Bao X, Xue SL, Shen H, et al. Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML. Blood 2023;142:1323-1327.
PMID: 37478399